CollPlant Biotechnologies (CLGN) EPS (Weighted Average and Diluted) (2019 - 2025)
CollPlant Biotechnologies (CLGN) reported EPS (Weighted Average and Diluted) of -$0.26 for Q4 2025, up 25.6% on a YoY basis from -$0.21 in Q4 2024, and down 192.19% quarter-over-quarter from $0.28 in Q2 2025.
CollPlant Biotechnologies (CLGN) EPS (Weighted Average and Diluted) (2019 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported EPS (Weighted Average and Diluted) for 7 years, with the latest figure at -$0.26 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 25.6% year-over-year to -$0.26; the trailing twelve-month figure through Dec 2025 stood at -$0.26 (up 25.6% YoY), and the FY2025 full-year result was -$0.94, up 35.17% from the prior year.
- EPS (Weighted Average and Diluted) for Q4 2025 stood at -$0.26, down from $0.28 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.88 in Q1 2021, with the low at -$0.44 in Q4 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged $0.08 across 5 years, with a median of $0.29 in 2021.
- The largest YoY upside for EPS (Weighted Average and Diluted) was 266.67% in 2021 against a maximum downside of 514.29% in 2021.
- CollPlant Biotechnologies' EPS (Weighted Average and Diluted) stood at -$0.3 in 2021, then slumped by 30.0% to -$0.39 in 2022, then declined by 14.1% to -$0.44 in 2023, then rose by 22.03% to -$0.35 in 2024, then advanced by 25.6% to -$0.26 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.26 (Q4 2025), $0.28 (Q2 2025), and -$0.35 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 0.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.61 |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.26 |
| Jun 30, 2025 | 0.28 |
| Dec 31, 2024 | -0.35 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.37 |
| Dec 31, 2023 | -0.44 |
| Jun 30, 2023 | 0.49 |
| Mar 31, 2023 | 0.33 |
| Dec 31, 2022 | -0.39 |
| Sep 30, 2022 | 0.40 |
| Jun 30, 2022 | -0.39 |
| Mar 31, 2022 | 0.36 |
| Dec 31, 2021 | -0.30 |
| Sep 30, 2021 | -0.29 |
| Jun 30, 2021 | 0.30 |
| Mar 31, 2021 | 0.88 |
| Dec 31, 2020 | -0.42 |
| Sep 30, 2020 | 0.07 |
| Jun 30, 2020 | 0.28 |
| Mar 31, 2020 | 0.24 |